肝细胞肝癌的靶向及免疫治疗研究现状与进展(5)
[17]Chen DS,Mellman I.Oncology meets immunology: the cancer-immunity cycle[J].Immunity,2013,39(1):1-10.[18]Sangro B,Gomez-Martin C,de la Mata M,et al.A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C[J].J Hepatol ......
您现在查看是摘要页,全文长 2432 字符。